98 related articles for article (PubMed ID: 20374388)
1. Fetuin-A and interleukin-18 levels in ankylosing spondylitis.
Sari I; Kebapcilar L; Taylan A; Bilgir O; Kozaci DL; Yildiz Y; Yuksel A; Gunay N; Akkoc N
Int J Rheum Dis; 2010 Feb; 13(1):75-81. PubMed ID: 20374388
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation].
Krzanowski M; Stompór T; Kuśnierz-Cabala B; Ignacak E; Sułowicz W; Naskalski JW
Przegl Lek; 2006; 63(8):597-601. PubMed ID: 17441364
[TBL] [Abstract][Full Text] [Related]
4. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
Park MC; Lee SW; Choi ST; Park YB; Lee SK
Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
8. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
9. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis.
Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D
Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449
[TBL] [Abstract][Full Text] [Related]
11. Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.
Przepiera-Będzak H; Fischer K; Brzosko M
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527149
[TBL] [Abstract][Full Text] [Related]
12. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis.
Peters MJ; van Eijk IC; Smulders YM; Serne E; Dijkmans BA; van der Horst-Bruinsma IE; Nurmohamed MT
J Rheumatol; 2010 Jan; 37(1):161-6. PubMed ID: 19955053
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
15. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
Taskapan MC; Taskapan H; Comert M; Temel I; Yagmur J; Ulutas O
Ren Fail; 2013; 35(4):477-82. PubMed ID: 23438291
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 levels are associated with low-density lipoproteins size.
Berneis K; Rizzo M; Evans J; Rini GB; Spinas GA; Goedecke JH
Eur J Clin Invest; 2010 Jan; 40(1):54-5. PubMed ID: 19968699
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
Visvanathan S; Wagner C; Marini JC; Baker D; Gathany T; Han J; van der Heijde D; Braun J
Ann Rheum Dis; 2008 Apr; 67(4):511-7. PubMed ID: 17644552
[TBL] [Abstract][Full Text] [Related]
18. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Protein oxidation status in patients with ankylosing spondylitis.
Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
